Keywords: novartis, presents, positive, late-stage, data, oral, dpp-4

Novartis presents positive late-stage data on oral DPP-4 drug Galvus at EASD

Article | 15 September 2008

Print This

Novartis claimed this week that new data presented at the 44th European Association for the Study of Diabetes meeting in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in